Literature DB >> 8731682

Indeterminate cell histiocytosis--a clinicopathological entity with features of both X- and non-X histiocytosis.

A Sidoroff1, B Zelger, H Steiner, N Smith.   

Abstract

An otherwise healthy 50-year-old woman presented with a 6-month history of having developed more than 100 generalized, non-confluent, reddish-brown, partially yellow-coloured papules. A non-epidemotropic, monomorphous infiltrate of vacuolated mononuclear, and occasionally multinuclear, histiocytes, positive for factor XIIIa and macrophage markers HAM56 and KiM1p, was consistent with the clinical impression of generalized eruptive histiocytomas. However, the additional reactivity for S100 protein, in the absence of features of histiocytosis X, suggested a diagnosis of indeterminate cell histiocytosis (ICH). Further immunohistochemical studies, performed on snap-frozen material, characterized the lesions as being diffusely positive with LN3 (HLA-DR), Leu4 (CD3) and Leu3 (CD4), the infiltrate in the upper dermis as reactive for OKT6 (CD1) and IOT6c (CD1c), and the infiltrate in the lower dermis as reactive for a variety of macrophage markers. Ultrastructural studies showed various non-specific features of histocytic disorders, but no Birbeck granules. Our findings confirm those of previous reports suggesting that ICH is a distinct histiocytic entity, characterized by immunophenotypic features of both X- and non-X histiocytoses. Generalized eruptive histiocytoma seems to be an early indeterminate stage of various non-X histiocytic syndromes including ICH, multicentric reticulohistiocytosis, xanthogranuloma and xanthoma disseminatum. The distribution pattern of the various X/non-X histiocytic markers suggests dermal arrest of antigen-presenting cells during their physiological trafficking from the skin to the lymph nodes.

Entities:  

Mesh:

Year:  1996        PMID: 8731682

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Indeterminate cell histiocytosis in a pediatric patient: successful treatment with thalidomide.

Authors:  Béla Tóth; Mária Katona; Judit Hársing; Agota Szepesi; Sarolta Kárpáti
Journal:  Pathol Oncol Res       Date:  2011-06-19       Impact factor: 3.201

2.  Generalized eruptive histiocytomas and rosai-dorfman disease presenting concurrently in a patient with myelodysplastic syndrome.

Authors:  Benjamin Kaffenberger; Kamruz Darabi; Sara Peters; Sara Peters; Jessica Kynyk; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

3.  Solitary Type of Congenital Self-healing Reticulohistiocytosis.

Authors:  Gantsetseg Dorjsuren; Hee Jung Kim; Jin Young Jung; Byung Gi Bae; Ju Hee Lee
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

4.  Indeterminate cell histiocytosis with naïve cells.

Authors:  Ola A Bakry; Rehab M Samaka; Mona A Kandil; Sheren F Younes
Journal:  Rare Tumors       Date:  2013-05-02

5.  Indeterminate cell histiocytosis in association with acute myeloid leukemia.

Authors:  Filipa Ventura; Teresa Pereira; Maria da Luz Duarte; Herlander Marques; Fernando Pardal; Celeste Brito
Journal:  Dermatol Res Pract       Date:  2010-06-21

6.  Recurrent Indeterminate Dendritic Cell Tumor of the Skin.

Authors:  Jin Woo Joo; Taek Chung; Yoon Ah Cho; Sang Kyum Kim
Journal:  J Pathol Transl Med       Date:  2018-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.